Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Archives of Dermatological Research
|
August 8, 2012
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients
Gabriele De Marco, Angelo Cattaneo, Norma Battafarano, et al.
Drug Development Research
|
November 11, 2014
The EPIPSOFIRE project: a preliminary report
Gabriele De Marco, Angelo Cattaneo, Carlo G Carrera, et al.
Journal of Drugs in Dermatology : JDD
|
December 21, 2020
Predicting Secukinumab Fast-Responder Profile in Psoriatic Patients: Advanced Application of Artificial-Neural-Networks (ANNs)
Giovanni Damiani, Rosalynn R Z Conic, Paolo D M Pigatto, et al.
Dermatology and Therapy
|
October 13, 2024
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luciano Ibba, Ruggero Cascio Ingurgio, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Dermatology and Therapy
|
May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Dermatology and Therapy
|
May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Archives of Dermatological Research
|
August 8, 2012
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients
Gabriele De Marco, Angelo Cattaneo, Norma Battafarano, et al.
Drug Development Research
|
November 11, 2014
The EPIPSOFIRE project: a preliminary report
Gabriele De Marco, Angelo Cattaneo, Carlo G Carrera, et al.
Journal of Drugs in Dermatology : JDD
|
December 21, 2020
Predicting Secukinumab Fast-Responder Profile in Psoriatic Patients: Advanced Application of Artificial-Neural-Networks (ANNs)
Giovanni Damiani, Rosalynn R Z Conic, Paolo D M Pigatto, et al.
Dermatology and Therapy
|
October 13, 2024
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luciano Ibba, Ruggero Cascio Ingurgio, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Dermatology and Therapy
|
May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Dermatology and Therapy
|
May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Page
of 2